In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients

International Journal of Antimicrobial Agents

Volumn 40, Issue 2, 2012, Pages 173-176

  Fernández Olmos, Ana ^a   García Castillo, María ^a   Maiz, Luis ^a   Lamas, Adelaida ^a   Baquero, Fernando ^a,b   Cantón, Rafael ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CSIC   (Spain)

Author keywords

Biofilm prevention concentration; Biofilms; Pseudomonas aeruginosa; Susceptibility testing

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; BIOFILM INHIBITORY CONCENTRATION; BIOFILM PREVENTION CONCENTRATION; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG CONCENTRATION; FEMALE; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIAL TYPING TECHNIQUES; BIOFILMS; CIPROFLOXACIN; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84864283580     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.04.006     Document Type: Article

References (15)

1. R. Cantón, N. Cobos, J. de Gracia, F. Baquero, J. Honorato, and S. Gartner Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients Clin Microbiol Infect 11 2005 690 703
2. B. Stuart, J.H. Lin, and P.J. Mogayzel Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis Paediatr Respir Rev 11 2010 177 184
3. D. Hill, B. Rose, A. Pajkos, M. Robinson, P. Bye, and S. Bell Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions J Clin Microbiol 43 2005 5085 5090
4. G. Doring, and N. Hoiby Early intervention and prevention of lung disease in cystic fibrosis: a European consensus J Cyst Fibros 3 2004 67 91
5. K.S. Korolev, J.B. Xavier, D.R. Nelson, and K.R. Foster A quantitative test of population genetics using spatiogenetic patterns in bacterial colonies Am Nat 178 2011 538 552
6. D. Grothues, U. Koopmann, H. Vonderhardt, and B. Tummler Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains J Clin Microbiol 26 1988 1973 1977
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
8. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0. EUCAST; 2012. http://www.eucast.org [accessed 25.04.12].
9. Clinical and Laboratory Standards Institute. Methods for determining bactericidal activity of antimicrobial agents; approved guidelines. Document M26-A. Wayne, PA: CLSI; 1999.
10. S.M. Moskowitz, J.M. Foster, J. Emerson, and J.L. Burns Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis J Clin Microbiol 42 2004 1915 1922
11. G.L. Drusano Antimicrobial pharmacodynamics: critical interactions of 'bug and drug' Nat Rev Microbiol 2 2004 289 300
12. D.E. Geller, W.H. Pitlick, P.A. Nardella, W.G. Tracewell, and B.W. Ramsey Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis Chest 122 2002 219 226
13. F. Ratjen, E. Rietschel, D. Kasel, R. Schwiertz, K. Starke, and H. Beier Pharmacokinetics of inhaled colistin in patients with cystic fibrosis J Antimicrob Chemother 57 2006 306 311
14. W. Hengzhuang, H. Wu, O. Ciofu, Z. Song, and N. Hoiby Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474
15. S.M. Moskowitz, J.C. Emerson, S. McNamara, R.D. Shell, D.M. Orenstein, and D. Rosenbluth Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection Pediatr Pulmonol 46 2011 184 192